Resistance Exercise Volume and Hypertrophic Response Variability in Elderly

December 5, 2024 updated by: Hamilton Augusto Roschel da Silva, University of Sao Paulo General Hospital

Effects of Resistance Exercise Volume on the Variability of the Hypertrophic Response in Elderly

The study aimed to investigate the effects of resistance training volume manipulation on whole muscle hypertrophy among non-responders and responders to a low resistance training dose (single-set).

Study Overview

Status

Completed

Detailed Description

The magnitude of muscle hypertrophy in response to resistance training (RT) is highly variable between individuals (response heterogeneity). Manipulations in RT variables may modulate RT-related response heterogeneity; yet, this remains to be determined.

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SP
      • Sao Paulo, SP, Brazil, 05508-030
        • University of Sao Paulo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 60 years and older
  • not engaged in regular resistance and/or aerobic training for at least six months before the intervention

Exclusion Criteria:

  • diagnosed type I diabetes mellitus
  • arrhythmia
  • noncontrolled hypertension
  • any major orthopedic musculoskeletal condition
  • use of any dietary supplement or drug with potential anabolic effects

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single set
One set of unilateral knee-extension exercise of 8-15 RM with a 60-90 s interval.
The RT protocol was performed using a unilateral knee-extension machine. To reduce potential sources of bias to exercise order, subjects alternated the starting leg for each training session.
Experimental: Four sets
Four sets of unilateral knee-extension exercise of 8-15 RM with a 60-90 s interval between sets.
The RT protocol was performed using a unilateral knee-extension machine. To reduce potential sources of bias to exercise order, subjects alternated the starting leg for each training session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quadriceps muscle cross-sectional area
Time Frame: 10 weeks
Quadriceps muscle CSA was obtained through magnetic resonance imaging.
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum dynamic strength
Time Frame: 10 weeks
Unilateral quadriceps 1-RM of both legs were assessed on a knee-extension machine
10 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary assessment
Time Frame: Before intervention
Dietary assemment using the USDA Automated Multiple-Pass Method
Before intervention
Mass spectrometry
Time Frame: 10 weeks
Mass spectrometry metabolomics
10 weeks
Skeletal muscle RNA-sequencing
Time Frame: 10 weeks
RNA sequencing using an Illumina NovaSeq Platform with a standard paired-end 150 bp (PE150) dual indexing protocol
10 weeks
Muscle protein measures
Time Frame: 10 weeks
Upstream binding factor (UBF) muscle protein was quantified by Simple Western capillary immunoassay.
10 weeks
Muscle protein measures
Time Frame: 10 weeks
v-Myc Avian Myelocytomatosis Viral Oncogene Homolog (c-Myc) muscle protein was quantified by Simple Western capillary immunoassay.
10 weeks
Muscle protein measures
Time Frame: 10 weeks
Frizzled class receptor 1 (Frizzled-1) muscle protein was quantified by Simple Western capillary immunoassay.
10 weeks
Muscle protein measures
Time Frame: 10 weeks
ribosomal protein L3 (rpL3) muscle protein was quantified by Simple Western capillary immunoassay.
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2018

Primary Completion (Actual)

December 20, 2018

Study Completion (Actual)

December 20, 2018

Study Registration Dates

First Submitted

December 1, 2024

First Submitted That Met QC Criteria

December 1, 2024

First Posted (Actual)

December 5, 2024

Study Record Updates

Last Update Posted (Estimated)

December 11, 2024

Last Update Submitted That Met QC Criteria

December 5, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 62590416.0.0000.5391

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Lower body resistance training

Subscribe